Drug Interaction Summary Table Heres a quick reference for common GLP-1 medication interactions, aimed at helping healthcare providers and patients navigate potential challenges
Dietary influences are the most common cause of stool colour variation: Green stools : leafy vegetables (spinach, kale), green food colouring Red or reddish stools : beetroot, tomatoes, red food dyes, cranberries Orange stools : foods high in beta-carotene (carrots, sweet potatoes), rifampicin (an antibiotic) Dark brown to black : iron supplements, bismuth subsalicylate, liquorice, blueberries Pale or light-coloured : primarily caused by reduced bile flow into the intestine Medications and supplements frequently alter stool appearance: Iron supplements commonly cause dark green or black stools Rifampicin and rifabutin can produce orange-red discolouration Bismuth subsalicylate causes black stools Some vitamins and herbal supplements contain pigments that pass through the digestive system Medical conditions that may affect stool colour include: Pale/clay-coloured : biliary obstruction, hepatitis, cirrhosis, pancreatic disorders Black/tarry : upper gastrointestinal bleeding (peptic ulcers, gastritis) Bright red : lower gastrointestinal bleeding (haemorrhoids, diverticular disease, colorectal pathology) Yellow/greasy : malabsorption syndromes, coeliac disease, chronic pancreatitis Green : rapid intestinal transit, certain infections Patients commencing GLP-1 therapy often simultaneously modify their diet significantly, increasing vegetable intake and reducing processed foods as part of weight management efforts
It omits GIP receptor activity but retains the glucagon component that differentiates it from pure GLP-1 agonists
Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the depression treatment [2]
The tirzepatide dosage protocol starts at 2.5 mg weekly with gradual increases, and Anthem typically wants to see this titration documented before approving ongoing coverage
PMID: 36841762
